<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/113DAE6A-FCEC-4797-8FCF-6A02C4C26200"><gtr:id>113DAE6A-FCEC-4797-8FCF-6A02C4C26200</gtr:id><gtr:name>AdProTec</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7C3729AA-933E-4E5E-A502-0DFA7E6E98AD"><gtr:id>7C3729AA-933E-4E5E-A502-0DFA7E6E98AD</gtr:id><gtr:name>Alexion Pharmaceuticals</gtr:name><gtr:address><gtr:line1>352 Knotter Drive</gtr:line1><gtr:postCode>CT 06410</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Immunology Infection and Inflam Diseases</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/113DAE6A-FCEC-4797-8FCF-6A02C4C26200"><gtr:id>113DAE6A-FCEC-4797-8FCF-6A02C4C26200</gtr:id><gtr:name>AdProTec</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7C3729AA-933E-4E5E-A502-0DFA7E6E98AD"><gtr:id>7C3729AA-933E-4E5E-A502-0DFA7E6E98AD</gtr:id><gtr:name>Alexion Pharmaceuticals</gtr:name><gtr:address><gtr:line1>352 Knotter Drive</gtr:line1><gtr:postCode>CT 06410</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/893D66CD-2721-4DA1-BC08-7050127B4B3A"><gtr:id>893D66CD-2721-4DA1-BC08-7050127B4B3A</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:otherNames>H</gtr:otherNames><gtr:surname>Sacks</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0000771"><gtr:id>03E15495-E40E-4101-BE99-EEEF992DB77B</gtr:id><gtr:title>Complement as a mediator of chronic injury in renal transplantation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0000771</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>833673</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Alexion Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Alexion Pharmaceuticals</gtr:description><gtr:id>08F7B846-110A-4129-B03B-C1B7139E9733</gtr:id><gtr:impact>The therapeutic antibody failed to penetrate into transplanted kidney and therefore helped to define types of injury that would not amenable to this particular therapeutic strategy.</gtr:impact><gtr:outcomeId>C3B90176623-1</gtr:outcomeId><gtr:partnerContribution>Alexion Pharmaveuticals provided Chemicals, Consumables and animals to this study</gtr:partnerContribution><gtr:piContribution>We collaborated on an investigator led pre clinical study to determine the impact of complement inhibitor (anti-C5) on reperfusion injury in native and transplant kidneys.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AdProTec</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AdProTec, UK</gtr:description><gtr:id>BB50A68F-08FE-4681-AC4B-438EC875B946</gtr:id><gtr:impact>Publications - Pubmed references 14507653 and 16510763 Joint patent application (Case 40336). This is now wholly owned by King's College London. Led to development of PhD project successfully awarded in 2006. Keynote symposium presentations including Presidents Lecture, Transplantation Society for Australia and New Zealand 2007.</gtr:impact><gtr:outcomeId>B033F968172-1</gtr:outcomeId><gtr:partnerContribution>The company provided chemicals and consumables for this study</gtr:partnerContribution><gtr:piContribution>1.Established the rationale of membrane targetting approach to prevent complement injury in donor kidney organs. 2. Enabled pre clinical study in prevention of reperfusion damage. 3. Enabled and led clinical (phase IIa) study to determine safety and feasibility of treating donor organs prior to transplantation.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Session Organiser for BSI 2013</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3991F3CC-42AA-455B-8E63-507698BFB7B8</gtr:id><gtr:impact>None as yet - Meeting occurring 2-5 December 2013</gtr:impact><gtr:outcomeId>Bi5LqS5quVC</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.bsicongress.com/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Patients' Association Open Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>0C84B917-C1FE-47B7-8757-FD3A7F9516E5</gtr:id><gtr:impact>Laboratory visit and talk concerning ongoing research.

Articles in National KPA newsletter.</gtr:impact><gtr:outcomeId>95FE00AAE7D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Patients Association Board Presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>29A87B9D-CEDF-452F-9917-4D3B58CDD437</gtr:id><gtr:impact>Summary of translational research including progress with complement inhibitors and potential therapeutics.

Ongoing funding notably &amp;pound;750K contribution to the MRC Centre for Transplantation.</gtr:impact><gtr:outcomeId>241791B6F27</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio 4 Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>81B8BD79-2F31-4AD1-ADDE-D7B58B892AE6</gtr:id><gtr:impact>Prof Steven Sacks describes his work on finding an easier way to get the body to accept a new organ on BBC Radio 4.

Publicity for the work of the MRC Centre for Transplantation.</gtr:impact><gtr:outcomeId>4270F550390</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Transplant Society Fellowship Award</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>British Transplantation Society (BTS)</gtr:fundingOrg><gtr:id>8B025C85-C9C3-489E-9FC8-6C02F16343D6</gtr:id><gtr:outcomeId>FD3EB77D75B0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E16AE00B-EA40-4042-A7ED-BC9F201E6143</gtr:id><gtr:outcomeId>7358415E8440</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>520000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>126390E6-EB0B-4E07-8328-E7BCEBD71817</gtr:id><gtr:outcomeId>D47A6C6AA080</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator award</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>2A7BB467-71B2-45D1-BD49-788F39A4FAC7</gtr:id><gtr:outcomeId>nbqVX6xSMhL</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6E10A97F-3A22-4026-82D3-3557EB04CDA0</gtr:id><gtr:outcomeId>DC3113112640</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>203000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Guy's &amp;amp; St Thomas' Charity Fellowship</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Guy?s &amp; St Thomas? Charity</gtr:fundingOrg><gtr:id>7BEE18B3-1E8F-497C-8BDB-0A5E2F6EF22F</gtr:id><gtr:outcomeId>7E5D17565F40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5369000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Comprehensive Biomedical Research Centre, Guy's and St Thomas</gtr:department><gtr:description>NIHR Biomedical Center Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>E9F04C84-4743-45E1-8C58-0D870AFF8CE6</gtr:id><gtr:outcomeId>60A83DB16D30</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD Studentship</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>20B73A3C-5D98-4A14-AE6F-5FDB20B563AE</gtr:id><gtr:outcomeId>640F843BDAE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>977000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Equipment Grant</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>B403A846-206D-4179-9C5D-6A6166387407</gtr:id><gtr:outcomeId>337EC180E140</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>220000</gtr:amountPounds><gtr:country>Ireland, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Opsona - pre clinical studies</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Opsona Therapeutics</gtr:fundingOrg><gtr:id>BB3C322E-B2C0-4C3A-A93F-7BEDACBA60FD</gtr:id><gtr:outcomeId>JCNSNk9tzQy</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>222000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A86E8289-71B2-4750-BE6F-04CF37C8BA7E</gtr:id><gtr:outcomeId>20550E1E88C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Technology Strategy Board Assessor Briefing for Healthcare</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2E722472-19C6-4BC4-9744-F85577955800</gtr:id><gtr:outcomeId>545ca1618df9e3.81311432</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Cloning of complement receptor 2 and modification to develop a new imaging tool for detection of complement activation by external body imaging.</gtr:description><gtr:id>3AA68732-90B2-4692-B229-4223A40ECDBE</gtr:id><gtr:impact>Work in progress.</gtr:impact><gtr:outcomeId>04DFAA43EF4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Complement imaging technology</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3CAD55F7-BBE8-43E0-8751-A47BBDC6CB7D</gtr:id><gtr:title>Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1303580cf747405066f520f753c1bca9"><gtr:id>1303580cf747405066f520f753c1bca9</gtr:id><gtr:otherNames>Patel H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>867BC2F8B89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5604E15C-D09A-4404-87E5-F58B546FA359</gtr:id><gtr:title>Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92e71281a7b654e3b4d9e3098f4ece2e"><gtr:id>92e71281a7b654e3b4d9e3098f4ece2e</gtr:id><gtr:otherNames>Peng Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>28709C74DB5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B912477-2908-4CB8-A5AA-4D2081C3747E</gtr:id><gtr:title>CD59a deficiency exacerbates ischemia-reperfusion injury in mice.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd5bd44f957e034ca84cb6028a9f8210"><gtr:id>bd5bd44f957e034ca84cb6028a9f8210</gtr:id><gtr:otherNames>Turnberg D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>5C0455A9244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18927538-D7A7-49AB-9467-D8D80C44BD58</gtr:id><gtr:title>Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/469ad8c6a9d2d0eeae548a0aa8bb4b8e"><gtr:id>469ad8c6a9d2d0eeae548a0aa8bb4b8e</gtr:id><gtr:otherNames>Rose KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>596D604102F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C59CC90-6A63-4820-BF78-068F78D91C1F</gtr:id><gtr:title>Local extravascular pool of C3 is a determinant of postischemic acute renal failure.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41571013db636d13570fa10eaf335ba"><gtr:id>f41571013db636d13570fa10eaf335ba</gtr:id><gtr:otherNames>Farrar CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>CF28A4D26FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54DAB9BD-77CC-46C2-BA50-E55DC950E200</gtr:id><gtr:title>Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b67d48f6a2d899d4784cd060f6832b1a"><gtr:id>b67d48f6a2d899d4784cd060f6832b1a</gtr:id><gtr:otherNames>Lin T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>2E7CCADAFCF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E44E8E1D-C7CF-4912-AAD2-B582053FC9A0</gtr:id><gtr:title>Independent pathways of P-selectin and complement-mediated renal ischemia/reperfusion injury.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41571013db636d13570fa10eaf335ba"><gtr:id>f41571013db636d13570fa10eaf335ba</gtr:id><gtr:otherNames>Farrar CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>337180036D0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>356157AD-5C3A-4F0D-8D7A-3422E61AA137</gtr:id><gtr:title>Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a4a3cd997f841d3d0f26f99aa36df9b"><gtr:id>7a4a3cd997f841d3d0f26f99aa36df9b</gtr:id><gtr:otherNames>Zhou W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>4DDA00B5A50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77F8E4E1-EA09-4334-BD99-FA73780812A6</gtr:id><gtr:title>Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92e71281a7b654e3b4d9e3098f4ece2e"><gtr:id>92e71281a7b654e3b4d9e3098f4ece2e</gtr:id><gtr:otherNames>Peng Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>7FB1126139F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D580460-0DD9-4EF5-ABDC-2DE29B9AD9B0</gtr:id><gtr:title>Mechanisms of disease: the complement system in renal injury--new ways of looking at an old foe.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bc22221e02b007ecc36e2cf2f985a7d"><gtr:id>1bc22221e02b007ecc36e2cf2f985a7d</gtr:id><gtr:otherNames>Brown KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1745-8323</gtr:issn><gtr:outcomeId>6E6E8951517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5B7CF24-1C3B-4F35-852E-ED44809ABFE2</gtr:id><gtr:title>The innate immune system and transplantation.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41571013db636d13570fa10eaf335ba"><gtr:id>f41571013db636d13570fa10eaf335ba</gtr:id><gtr:otherNames>Farrar CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>pm_13110_20_24086066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05B8521D-3612-46E9-AC12-3B71EC9DA887</gtr:id><gtr:title>Complement-here, there and everywhere, but what about the transplanted organ?</gtr:title><gtr:parentPublicationTitle>Seminars in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e7acccc697d335a9c9faa7f6a259c1"><gtr:id>08e7acccc697d335a9c9faa7f6a259c1</gtr:id><gtr:otherNames>Montero RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1044-5323</gtr:issn><gtr:outcomeId>58c6b5f9b562e3.90532659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A61CA8F-CE6F-4401-B616-DD8700B72BAF</gtr:id><gtr:title>New boundaries for complement in renal disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c12df69d984c2e012769607eaadd6a4"><gtr:id>8c12df69d984c2e012769607eaadd6a4</gtr:id><gtr:otherNames>Sacks S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>E4E116FDDF0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34B79247-1B7B-4C2D-BC57-95CEFD948DE3</gtr:id><gtr:title>Membrane-localising complement inhibitors-clinical progress</gtr:title><gtr:parentPublicationTitle>Molecular Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd3f7bdd77d0a480311e5acfbb11500b"><gtr:id>fd3f7bdd77d0a480311e5acfbb11500b</gtr:id><gtr:otherNames>Smith R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>3EE19E0225A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8FBDCF8-EA2D-4080-B4A6-DD194A4ED168</gtr:id><gtr:title>Role of dendritic cell synthesis of complement in the allospecific T cell response.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a4a3cd997f841d3d0f26f99aa36df9b"><gtr:id>7a4a3cd997f841d3d0f26f99aa36df9b</gtr:id><gtr:otherNames>Zhou W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>24DD69A6754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>740D4DD2-70AF-49D7-B71D-3FDA71787236</gtr:id><gtr:title>Complement in organ transplantation.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a316adfc796e81a38c1044af9c04fdd4"><gtr:id>a316adfc796e81a38c1044af9c04fdd4</gtr:id><gtr:otherNames>Asgari E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>bSTZfwRyX74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>215BD263-2AFF-4CBF-9AEE-F663E7A9F44A</gtr:id><gtr:title>Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>F1998EC558D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78080CCC-A8B2-49BB-A1F4-6F93C57B34EE</gtr:id><gtr:title>Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>3110222B077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>726DA49F-DFE7-43AE-AD2A-13F82B0B2745</gtr:id><gtr:title>The role of complement and Toll-like receptors in organ transplantation.</gtr:title><gtr:parentPublicationTitle>Transplant international : official journal of the European Society for Organ Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b67d48f6a2d899d4784cd060f6832b1a"><gtr:id>b67d48f6a2d899d4784cd060f6832b1a</gtr:id><gtr:otherNames>Lin T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0934-0874</gtr:issn><gtr:outcomeId>6934A424126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE751F27-6DD0-42D2-AD75-4C9359959E81</gtr:id><gtr:title>Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5dba42c9a661e7f3a5d2c9d7fe2a96fe"><gtr:id>5dba42c9a661e7f3a5d2c9d7fe2a96fe</gtr:id><gtr:otherNames>Sheerin NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>51362C66A6C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B27F65C9-6561-4A15-A73D-154F47F8CF52</gtr:id><gtr:title>Influence of donor C3 allotype on late renal-transplantation outcome.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bc22221e02b007ecc36e2cf2f985a7d"><gtr:id>1bc22221e02b007ecc36e2cf2f985a7d</gtr:id><gtr:otherNames>Brown KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>4830EBD50FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1595B2C-BC5B-4D87-A1A6-DEBE7E3DAE0D</gtr:id><gtr:title>The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>136A89A8FC0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB2D959D-5A0A-4810-AF9A-23A68975764C</gtr:id><gtr:title>Allograft rejection: effect of local synthesis of complement.</gtr:title><gtr:parentPublicationTitle>Springer seminars in immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9ec214617661fdfb7e5229c6dcdcbf"><gtr:id>ff9ec214617661fdfb7e5229c6dcdcbf</gtr:id><gtr:otherNames>Sacks SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0344-4325</gtr:issn><gtr:outcomeId>2A5CE663B91</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0000771</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>78E3B265-B307-4D06-9AB7-1F69471E721F</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.4  Surgery</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>